Jun 08, 2023 / 06:00PM GMT
Xuyang Li - Jefferies LLC, Research Division - Equity Analyst
All right. Why don't we kick the session off. Good afternoon, everyone. Welcome to day 2 of the Jefferies New York Healthcare Conference. My name Xuyang Li, one of the med-tech analysts in the U.S. team. Really pleased to be joined by management from Cooper. We have Dan McBride, EVP and COO; and Kim Duncan, VP IR. So this would be a moderated Q&A session. Dan, Kim, welcome, and thanks for coming.
Daniel G. McBride - The Cooper Companies, Inc. - Executive VP & COO
Thank you.
Questions and Answers:
Xuyang Li - Jefferies LLC, Research Division - Equity AnalystSo I guess, why don't we start with recent performance. You just reported results last week, solid beats on the top line and EPS. CVI leading the charge. Would be great maybe if you can talk a little bit about some of the growth drivers within the Vision Care business and what you're seeing in the market?
Daniel G. McBride - The Cooper Companies, Inc. -
Trustpilot
